• Peter Reynolds, Stamatina Leontiadi, Tracy Lawson, Tosin Otunla, Olayinka Ejiwumi, and Nicola Holland.
• Neonatal Intensive Care Unit, St. Peter's Hospital, Ashford and St. Peter's Hospitals NHS Foundation Trust, Chertsey, UK.
• Arch. Dis. Child. Fetal Neonatal Ed. 2016 Jul 1; 101 (4): F284-7.

ObjectiveThis was a pilot study to determine the feasibility of using nasal high flow (nHF) (also known as heated humidified high-flow nasal cannula) for stabilisation of babies born at <30 weeks gestation in the delivery room (DR) and transfer to the neonatal intensive care unit (NICU).DesignObservational study.SettingSingle-centre NICU.PatientsInfants born at <30 weeks gestation.InterventionsStabilisation and transfer to NICU using nHF.Main Outcome MeasuresFeasibility of stabilisation as defined by successful transfer and clinical measures of stability at admission to NICU including oxygen requirement, temperature, requirement for surfactant and inotrope use within 72 h of delivery.ResultsTwenty-eight babies were enrolled after written parental consent had been obtained. 25/28 were successfully stabilised in the DR and transferred to the NICU on nHF. The average admission temperature for babies transferred on nHF was 36.9°C and the average inspired oxygen at admission was 29%. Less than half (48%) required surfactant and 60% were still on nHF 72 h after admission. 1 baby received inotropes.ConclusionsOur study suggests that using nHF for stabilisation of premature infants in the DR and subsequent transfer to NICU is feasible.Clinical Trial Registration NumberNCT01991886.Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/

27 keywords...

hide…